1312 Share Price Performance
HK$0.028
-0.01 (-15.15%)
Price HK$0.028
Share PriceHK$0.028
Kontafarma China Holdings Limited (HKG:1312) Held Back By Insufficient Growth Even After Shares Climb 33%
Sep 17
Kontafarma China Holdings Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
1312 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Kontafarma China Holdings Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.065
- 55.36%
- -40.68%
- 13.2%
About 1312
- Founded
- 2011
- Employees
- 655
- CEO
- WebsiteView website
Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally. It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities. It also offers corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
